Robert Pietrusko

Chief Regulatory & Quality Officer at Vor Biopharma, Inc.

Robert Pietrusko

Robert Pietrusko

Chief Regulatory & Quality Officer at Vor Biopharma, Inc.

Overview
RelSci Relationships

490

Birthday

1948

Age

73

Contact Data
Trying to get in touch with Robert Pietrusko? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Robert Pietrusko likely has professional access to. A relationship does not necessarily indicate a personal connection.

Former Vice President-Technology Development at Shire ViroPharma, Inc.

Relationship likelihood: Average

Co-Founder at Third Rock Ventures LLC

Relationship likelihood: Average

Chief Financial Officer at Jounce Therapeutics, Inc.

Relationship likelihood: Average

President, Chief Executive Officer & Director at Vor Biopharma, Inc.

Relationship likelihood: Average

Chief Financial Officer at Vor Biopharma, Inc.

Relationship likelihood: Average

Chief Technology Officer at Vor Biopharma, Inc.

Relationship likelihood: Average

Chief Commercial Officer at Vor Biopharma, Inc.

Relationship likelihood: Average

Chief Scientific Officer at Vor Biopharma, Inc.

Relationship likelihood: Average

Chief Legal Officer at Vor Biopharma, Inc.

Relationship likelihood: Average

Chief Medical Officer at Vor Biopharma, Inc.

Relationship likelihood: Average

Paths to Robert Pietrusko
Potential Connections via
Relationship Science
You
Robert Pietrusko
Chief Regulatory & Quality Officer at Vor Biopharma, Inc.
Education
Bachelor of Pharmacy Unknown

Rutgers, The State University of New Jersey, is a leading national research university and the state’s preeminent, comprehensive public institution of higher education. Rutgers is dedicated to teaching that meets the highest standards of excellence; to conducting research that breaks new ground; and to providing services, solutions, and clinical care that help individuals and the local, national, and global communities where they live. Founded in 1766, Rutgers teaches across the full educational spectrum: preschool to precollege; undergraduate to graduate; postdoctoral fellowships to residencies; and continuing education for professional and personal advancement.

Philadelphia University was founded in 1884 as the Philadelphia Textile School in the wake of the 1876 Centennial Exposition. A group of textile manufacturers, led by Theodore Search, noticed a sizeable gap between the quality and variety of American textile products and those displayed by European mills. To address this, the group established the School to educate America’s textile workers and managers. Several years later, the School affiliated with the Pennsylvania Museum (now the Philadelphia Museum of Art) and School of Industrial Art. By 1949, PTI, which was no longer affiliated with the museum, began conducting classes at its present site in the East Falls section of Philadelphia. Throughout the 1950s, it continued to grow, and, in 1961, changed its name to Philadelphia College of Textiles & Science. The Board of Trustees voted to change the School’s name to Philadelphia University on July 13, 1999.

Doctor of Pharmacy Unknown

The Philadelphia College of Osteopathic Medicine (PCOM) is a graduate college located in Philadelphia, in the US state Pennsylvania. PCOM is one of the oldest and largest osteopathic medical schools in the United States. Founded in 1899, PCOM is home to over 1,800 students. PCOM offers degree programs in osteopathic medicine, pharmacy, psychology, business (MBA), and forensic medicine. In 2005, PCOM opened a second campus in Suwanee, Georgia. PCOM also operates five primary care clinics, residency programs for physicians, and a Center for Chronic Disorders of Aging. All of the programs at PCOM have professional accreditation. PCOM is accredited by the Middle States Association of Colleges and Schools. The Doctor of Osteopathic Medicine (DO) program is accredited by the American Osteopathic Association.

Career History
Senior Vice President-Worldwide Regulatory Affairs
2001 - 2007

Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA.

Vice President-Regulatory Affairs
1999 - 2000

GlaxoSmithKline Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the following segments: Pharmaceuticals; Pharmaceuticals R&D; Vaccines and Consumer Healthcare. The Pharmaceuticals segment focuses on developing medicines in respiratory and infectious diseases, oncology, and immuno-inflammation. The Pharmaceuticals R&D segment focuses on science related to the immune system, the use of human genetics and advanced technologies, and is driven by the multiplier effect of Science x Technology x Culture. The Vaccines segment produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza, and bacterial meningitis. The Consumer Healthcare segment develops and markets brands in the oral health, pain relief, respiratory, nutrition and gastro intestinal, and skin health categories. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.

Senior Vice President-Global Regulatory Affairs & Quality
Prior - 2014

ViroPharma Incorporated is an international biopharmaceutical company committed to developing and commercializing innovative products that address unmet medical needs. We focus on providing products to physician specialists that support patients with serious diseases for which there is an unmet medical need, including disease caused by C1 esterase inhibitor deficiency and C. difficile. In everything we do, throughout our organization, we are committed to patient and physician needs, as we work to bring new products to markets with few, if any, therapeutic options. We are dedicated to transforming the promise of biotechnology into therapies that have the power to restore health and save lives.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Robert Pietrusko. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Robert Pietrusko's profile does not indicate a business or promotional relationship of any kind between RelSci and Robert Pietrusko.